GLSI
Greenwich LifeSciences, Inc.
Company overview
- Market capitalization
- $272.87M
- Employees
- 4
- Latest publication
- 2026-09-29
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,558USD | 0USD | 0USD | 3,612USD | 0USD | 0USD | 0USD | 5,418USD |
| Cost Of Revenue | 1,779USD | — | 876USD | 903USD | — | 903USD | 903USD | 903USD |
| Gross Profit | 1,779USD | — | -876USD | -903USD | — | -903USD | -903USD | -903USD |
| Research Development | 3,521,576USD | 3,521,576USD | 3,507,906USD | 2,601,122USD | 6,157,603USD | 2,292,040USD | 2,307,873USD | 2,194,513USD |
| Selling General Administrative | 653,066USD | 653,066USD | 538,047USD | 681,210USD | 1,926,558USD | 437,011USD | 353,531USD | 342,688USD |
| Total Operating Expenses | 4,174,642USD | 4,174,642USD | 4,045,953USD | 3,282,332USD | 8,084,161USD | 2,729,051USD | 2,661,404USD | 2,536,298USD |
| Operating Income | 7,328,285USD | -4,174,642USD | -4,045,953USD | -3,282,332USD | -8,084,161USD | -2,729,051USD | -2,661,404USD | -2,537,200USD |
| Income Before Tax | -4,151,845USD | -4,151,845USD | -4,025,278USD | -3,258,362USD | -8,040,219USD | -2,668,713USD | -2,606,682USD | -2,473,195USD |
| Net Income | -4,151,845USD | -4,151,845USD | -4,025,278USD | -3,258,362USD | -8,040,219USD | -2,668,713USD | -2,606,682USD | -2,473,195USD |
| Ebit | 7,328,285USD | — | -4,045,953USD | -3,282,332USD | -8,084,161USD | -2,729,051USD | -2,661,404USD | -2,537,201USD |
| Ebitda | 7,326,506USD | -4,151,845USD | -4,045,077USD | -3,281,429USD | — | -2,728,148USD | -2,660,501USD | -2,536,298USD |
| Depreciation And Amortization | -1,779USD | — | 876USD | 903USD | — | 903USD | 903USD | 903USD |
| Total Other Income Expense Net | -11,480,130USD | 22,797USD | 20,675USD | 23,970USD | — | 60,338USD | 54,722USD | 64,006USD |
| Interest Income | — | 22,797USD | 20,675USD | 23,970USD | 43,942USD | 60,338USD | 54,722USD | 64,006USD |
| Net Interest Income | — | 22,797USD | 20,675USD | 23,970USD | 43,942USD | 60,338USD | 54,722USD | 64,006USD |
| Net Income From Continuing Ops | — | -4,151,845USD | -4,025,278USD | -3,258,362USD | -8,040,219USD | -2,668,713USD | -2,606,682USD | -2,473,195USD |
| Reconciled Depreciation | — | 0USD | 876USD | 903USD | 903USD | 903USD | 903USD | 903USD |
| Selling And Marketing Expenses | — | — | — | 903USD | — | — | 903USD | 903USD |
| Interest Expense | — | — | — | 223,008USD | — | — | — | 116,180USD |
| Income Tax Expense | — | — | — | 2,538,104USD | — | — | -3USD | -3USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 3,612USD | 3,612USD | 3,612USD | 3,612USD | 3,609USD | 3,607USD | 3,607USD | 3,607USD |
| Gross Profit | -3,612USD | -3,612USD | -3,612USD | -3,612USD | -3,609USD | -3,607USD | -3,607USD | -3,607USD |
| Research Development | 12,952,029USD | 7,698,622USD | 6,475,668USD | 3,559,515USD | 1,057,606USD | 2,606,420USD | 1,270,016USD | 1,223,051USD |
| Selling General Administrative | 3,059,788USD | 1,629,244USD | 1,564,586USD | 1,038,428USD | 806,188USD | 818,887USD | 419,639USD | — |
| Total Operating Expenses | 16,011,817USD | 9,327,866USD | 8,040,254USD | 4,597,943USD | 1,863,794USD | 3,425,307USD | 1,689,655USD | 1,569,863USD |
| Operating Income | -16,011,817USD | -9,327,866USD | -8,040,254USD | -4,597,943USD | -1,863,794USD | -3,425,307USD | -1,689,655USD | -1,573,470USD |
| Interest Income | 223,008USD | 450,940USD | 215,017USD | 27,367USD | 832USD | — | — | — |
| Net Interest Income | 223,008USD | 450,940USD | 215,017USD | 27,367USD | 832USD | — | — | — |
| Income Before Tax | -15,788,809USD | -8,891,803USD | -7,825,237USD | -4,570,576USD | -1,862,962USD | -3,425,307USD | -1,689,655USD | -1,573,470USD |
| Net Income | -15,788,809USD | -8,891,803USD | -7,825,237USD | -4,570,576USD | -1,862,130USD | -3,425,307USD | -1,689,655USD | -1,573,470USD |
| Net Income From Continuing Ops | -15,788,809USD | -8,935,576USD | -7,825,237USD | -4,570,576USD | -1,862,962USD | -3,425,307USD | -1,689,655USD | — |
| Ebit | -15,788,809USD | -9,327,866USD | -8,040,254USD | -4,597,943USD | -1,863,794USD | -3,425,307USD | -1,689,655USD | -1,573,467USD |
| Ebitda | -15,785,197USD | -9,324,254USD | -8,036,642USD | -4,594,331USD | -1,860,185USD | -3,421,700USD | -1,686,048USD | -1,569,860USD |
| Depreciation And Amortization | 3,612USD | 3,612USD | 3,612USD | 3,612USD | 3,609USD | 3,607USD | 3,607USD | 3,607USD |
| Reconciled Depreciation | 3,612USD | 3,612USD | 3,612USD | 3,612USD | 3,609USD | 3,607USD | 3,607USD | — |
| Total Other Income Expense Net | 223,008USD | 436,063USD | 215,017USD | 27,367USD | 832USD | 3USD | — | — |
| Selling And Marketing Expenses | — | 3,612USD | — | — | — | — | — | — |
| Income Tax Expense | — | -2USD | -215,017USD | -27,367USD | -832USD | 3USD | -157,534USD | 3USD |
| Interest Expense | — | — | 215,017USD | 27,367USD | 0USD | 0USD | 0USD | — |
| Non Operating Income Net Other | — | — | — | 27,367USD | 832USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -4,570,576USD | -1,862,962USD | -3,425,307USD | -1,689,655USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,876,353USD | 3,806,978USD | 3,125,101USD | 2,750,835USD | 4,093,769USD | 5,825,049USD | 7,228,460USD | 5,510,463USD |
| Total Current Assets | 8,876,353USD | 3,806,978USD | 3,125,101USD | 2,749,959USD | 4,091,990USD | 5,825,049USD | 7,224,875USD | 5,505,975USD |
| Total Liabilities | 5,759,396USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,759,396USD | 1,622,000USD | 1,685,609USD | 1,438,524USD | 1,559,733USD | 842,384USD | 1,353,028USD | 389,611USD |
| Total Stockholder Equity | 3,116,957USD | 2,184,977USD | 1,439,492USD | 1,312,311USD | 2,534,036USD | 4,982,665USD | 5,875,432USD | 5,120,852USD |
| Total Equity Including Noncontrolling Interest | 3,116,957USD | — | — | — | — | — | — | — |
| Accounts Payable | 4,807,655USD | 1,108,886USD | 1,075,631USD | 827,036USD | 1,177,536USD | 774,759USD | 1,114,386USD | 125,737USD |
| Common Stock | 14,678USD | 13,795USD | 13,473USD | 13,193USD | — | 13,145USD | 13,068USD | 12,876USD |
| Retained Earnings | -96,742,818USD | -77,588,863USD | -73,437,018USD | -69,411,740USD | -66,153,378USD | -58,113,159USD | -55,444,446USD | -52,837,764USD |
| Total Liab | — | 1,622,000USD | 1,685,609USD | 1,438,524USD | 1,559,733USD | 842,384USD | 1,353,028USD | 389,611USD |
| Other Current Liab | — | 513,114USD | 609,978USD | 611,488USD | — | 67,625USD | 238,642USD | 263,874USD |
| Capital Stock | — | 13,795USD | 13,473USD | 13,193USD | 13,153USD | 13,145USD | 13,068USD | 12,876USD |
| Cash | — | 3,806,978USD | 3,125,101USD | 2,749,959USD | 4,091,990USD | 5,822,367USD | 7,224,875USD | 5,505,975USD |
| Cash And Short Term Investments | — | 3,806,978USD | 3,125,101USD | 2,749,959USD | — | 5,822,367USD | 7,224,875USD | 5,505,975USD |
| Net Debt | — | -3,806,978USD | -3,125,101USD | -2,749,959USD | — | -5,822,367USD | -7,224,875USD | -5,505,975USD |
| Common Stock Shares Outstanding | — | 13,641,384shares | 13,370,983shares | 13,171,555shares | 13,152,729shares | 13,142,457shares | 12,906,867shares | 12,859,685shares |
| Non Current Assets Total | — | 0USD | 0USD | 876USD | 1,779USD | 2,682USD | 3,585USD | 4,487USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Working Capital | — | 2,184,977USD | 1,439,492USD | 1,312,311USD | 2,532,257USD | 4,982,665USD | 5,871,847USD | 5,116,364USD |
| Unclassified Equity | — | 79,746,250USD | 74,849,564USD | 70,697,665USD | 68,674,261USD | 63,069,534USD | 61,293,742USD | 57,932,864USD |
| Intangible Assets | — | — | — | 876USD | 1,779USD | 2,682USD | 3,585USD | 4,488USD |
| Other Current Assets | — | — | — | 876USD | — | 2,682USD | 3,585USD | — |
| Other Assets | — | — | — | 876USD | — | 2,682USD | — | 0USD |
| Non Currrent Assets Other | — | — | — | 1,779USD | — | — | 0USD | 0USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | -6,738,796USD | 4,093,769USD | 6,994,815USD | 13,477,029USD | 27,216,884USD | 28,676,602USD | 26,671USD | 108,545USD |
| Total Liab | 2,016,615USD | 1,559,733USD | 294,406USD | 262,905USD | 385,172USD | 1,045,492USD | 1,377,089USD | 10,228,599USD |
| Total Stockholder Equity | 1,790,363USD | 2,534,036USD | 6,700,409USD | 13,214,124USD | 26,831,712USD | 27,631,110USD | -1,350,418USD | -10,120,054USD |
| Cash | -6,738,796USD | 4,091,990USD | 6,989,424USD | 13,468,026USD | 27,204,269USD | 28,660,375USD | 6,835USD | 85,102USD |
| Cash And Short Term Investments | -6,738,796USD | 4,091,990USD | 6,989,424USD | 13,468,026USD | 27,204,269USD | 28,660,375USD | 6,835USD | 85,102USD |
| Total Current Assets | -6,738,796USD | 4,091,990USD | 6,989,424USD | 13,468,026USD | 27,204,269USD | 28,660,375USD | 6,835USD | 85,102USD |
| Net Debt | 6,738,796USD | -4,091,990USD | -6,989,424USD | -13,468,026USD | -27,204,269USD | -28,385,221USD | 628,319USD | -85,102USD |
| Unclassified Current Assets | -6,738,796USD | — | — | — | — | — | — | — |
| Unclassified Equity | 1,790,363USD | 68,661,108USD | 57,039,282USD | 54,661,194USD | 60,452,945USD | 56,682,655USD | 25,844,676USD | 13,665,904USD |
| Intangible Assets | — | 1,779USD | 5,391USD | 9,003USD | 12,615USD | 16,227USD | 19,836USD | 23,443USD |
| Other Current Liab | — | 382,197USD | 258,934USD | 262,905USD | 385,172USD | 59,367USD | 11,626USD | 451,043USD |
| Common Stock | — | 13,153USD | 12,848USD | 12,848USD | 13,148USD | 12,704USD | 8,458USD | 542USD |
| Capital Stock | — | 13,153USD | 12,848USD | 12,848USD | 13,148USD | 12,704USD | 10,439USD | 2,184USD |
| Retained Earnings | — | -66,153,378USD | -50,364,569USD | -41,472,766USD | -33,647,529USD | -29,076,953USD | -27,213,991USD | -23,788,684USD |
| Other Assets | — | 1,779USD | 0USD | -8,994USD | -12,602USD | 16USD | — | — |
| Total Current Liabilities | — | 1,559,733USD | 294,406USD | 262,905USD | 385,172USD | 1,045,492USD | 1,377,089USD | 728,599USD |
| Accounts Payable | — | 1,177,536USD | 35,472USD | 220,845USD | 220,845USD | 710,971USD | 730,309USD | 277,556USD |
| Common Stock Shares Outstanding | — | 13,014,585shares | 12,848,165shares | 12,913,848shares | 12,944,134shares | 12,703,541shares | 11,743,555shares | 11,970,185shares |
| Non Current Assets Total | — | 1,779USD | 5,391USD | 9,003USD | 12,615USD | 16,227USD | 19,836USD | 23,443USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 730,309USD | 9,500,000USD |
| Net Working Capital | — | 2,532,257USD | 6,695,018USD | 13,205,121USD | 26,819,097USD | 27,614,883USD | -1,370,254USD | -643,497USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | 0USD | 0USD | — | — |
| Non Currrent Assets Other | — | — | 0USD | 0USD | 0USD | 0USD | — | — |
| Net Tangible Assets | — | — | — | — | 26,819,097USD | 27,614,883USD | -1,375,542USD | -10,148,785USD |
| Current Deferred Revenue | — | — | — | — | — | -275USD | -635USD | -420,154USD |
| Short Term Debt | — | — | — | — | — | 275,154USD | 635,154USD | — |
| Short Long Term Debt Total | — | — | — | — | — | 275,154USD | 635,154USD | 420,154USD |
| Other Liab | — | — | — | — | — | — | — | 9,500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 3,028,976USD |
| Change To Liabilities | 154,011USD |
| Change In Working Capital | -65,408USD |
| Operating Cash Flow | -6,642,244USD |
| Financing Cash Flow | 9,340,576USD |
| Change In Cash | 2,698,332USD |
| End Cash Flow | 8,876,353USD |
| Source | DisclosureDeterministicFinal |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -19,358,218USD | -15,788,809USD | -8,891,803USD | -7,825,237USD | -4,570,576USD | -1,862,962USD | -3,425,307USD | -1,689,655USD |
| Depreciation | 1,779USD | 3,612USD | 3,612USD | 3,612USD | 3,612USD | 3,609USD | 3,607USD | 3,607USD |
| Stock Based Compensation | 6,803,325USD | 7,253,327USD | 2,378,088USD | 1,743,865USD | 660,582USD | 677,988USD | 194,943USD | — |
| Other Non Cash Items | 2,639,661USD | 1,265,327USD | 35,472USD | 1,751,089USD | 1,194,538USD | 777,756USD | -2USD | -73,753USD |
| Total Cash From Operating Activities | -9,913,453USD | -7,266,543USD | -6,478,602USD | -6,200,027USD | -4,291,548USD | -1,152,962USD | -293,267USD | -114,952USD |
| Capital Expenditures | 0USD | -3USD | 0USD | -3USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -9,913,453USD | -7,266,543USD | -6,478,602USD | -6,200,027USD | -4,291,548USD | -1,152,962USD | -293,267USD | -114,952USD |
| Total Cash From Financing Activities | 11,999,484USD | 4,369,109USD | 0USD | -7,536,216USD | 2,835,442USD | 29,806,502USD | 215,000USD | 200,000USD |
| Change In Cash | 2,086,031USD | -2,897,434USD | -6,478,602USD | -13,736,243USD | -1,456,106USD | 28,653,540USD | -78,267USD | 85,048USD |
| Begin Period Cash Flow | 4,091,990USD | 6,989,424USD | 13,468,026USD | 27,204,269USD | 28,660,375USD | 6,835USD | 85,102USD | 54USD |
| End Period Cash Flow | 6,178,021USD | 4,091,990USD | 6,989,424USD | 13,468,026USD | 27,204,269USD | 28,660,375USD | 6,835USD | 85,102USD |
| Other Cashflows From Financing Activities | 11,999,484USD | 4,369,109USD | — | -7,536USD | -275,154USD | -360,000USD | 215,000USD | 200,000USD |
| Change In Working Capital | — | 1,265,327USD | 31,501USD | -122,267USD | -385,166USD | 28,403USD | 2,933,492USD | 1,571,096USD |
| Issuance Of Capital Stock | — | 4,369,109USD | 0USD | 562,596USD | 3,110,596USD | 30,166,502USD | 0USD | — |
| Unclassified Operating Cash Flow | — | -1,265,327USD | — | -1,751,089USD | -1,194,538USD | — | — | — |
| Unclassified Financing Cash Flow | — | -4,369,109USD | — | — | — | — | — | — |
| Sale Purchase Of Stock | — | — | 0USD | -7,536,216USD | 3,110,596USD | 30,166,502USD | — | — |
| Change To Liabilities | — | — | — | — | -385,166USD | -92,550USD | 393,402USD | 80,967USD |
| Net Borrowings | — | — | — | — | -275,154USD | -360,000USD | 215,000USD | 100,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -1,456,106USD | 28,653,540USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,151,845USD | -4,025,278USD | -3,258,362USD | -8,040,220USD | -2,668,713USD | -2,606,682USD | -2,473,195USD | -2,746,740USD |
| Depreciation | 0USD | 876USD | 903USD | 903USD | 903USD | 903USD | 903USD | 903USD |
| Stock Based Compensation | 1,544,214USD | 1,544,214USD | 1,544,214USD | 5,469,761USD | 594,522USD | 594,522USD | 594,522USD | 594,522USD |
| Other Non Cash Items | 62,268USD | — | 1,265,327USD | — | 547,978USD | -392,321USD | 570,913USD | — |
| Change In Working Capital | -63,608USD | 247,085USD | -121,209USD | 717,349USD | -510,644USD | 963,417USD | 95,205USD | -2,881USD |
| Total Cash From Operating Activities | -2,671,239USD | -2,233,103USD | -1,834,454USD | -1,852,206USD | -2,583,932USD | -1,047,840USD | -1,782,565USD | -2,154,195USD |
| Capital Expenditures | -7USD | -3USD | -4USD | 0USD | 0USD | 0USD | -5USD | 0USD |
| Free Cash Flow | -2,671,239USD | -2,233,103USD | -1,834,454USD | -1,852,206USD | -2,583,932USD | -1,047,840USD | -1,782,565USD | -2,154,195USD |
| Total Cash From Financing Activities | 3,353,116USD | 2,608,245USD | 492,423USD | 121,829USD | 1,181,424USD | 2,766,740USD | 299,116USD | 0USD |
| Issuance Of Capital Stock | 3,208,116USD | 2,608,245USD | 492,423USD | 121,829USD | 1,181,424USD | 2,766,740USD | 299,116USD | — |
| Change In Cash | 681,877USD | 375,142USD | -1,342,031USD | -1,730,377USD | -1,402,508USD | 1,718,900USD | -1,483,449USD | -2,154,195USD |
| Begin Period Cash Flow | 3,125,101USD | 2,749,959USD | 4,091,990USD | 5,822,367USD | 7,224,875USD | 5,505,975USD | 6,989,424USD | 9,143,619USD |
| End Period Cash Flow | 3,806,978USD | 3,125,101USD | 2,749,959USD | 4,091,990USD | 5,822,367USD | 7,224,875USD | 5,505,975USD | 6,989,424USD |
| Other Cashflows From Financing Activities | 145,000USD | — | 4,369,109USD | — | 1,181,424USD | 2,766,740USD | 299,116USD | — |
| Unclassified Operating Cash Flow | — | — | -1,265,327USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | -4,369,109USD | — | -1,181,424USD | -2,766,740USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.